Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Arcadia Biosciences, Inc. | rkda-10k_20191231.htm |
| EX-32.2 - EX-32.2 - Arcadia Biosciences, Inc. | rkda-ex322_8.htm |
| EX-32.1 - EX-32.1 - Arcadia Biosciences, Inc. | rkda-ex321_9.htm |
| EX-31.2 - EX-31.2 - Arcadia Biosciences, Inc. | rkda-ex312_7.htm |
| EX-31.1 - EX-31.1 - Arcadia Biosciences, Inc. | rkda-ex311_6.htm |
| EX-10.8 - EX-10.8 - Arcadia Biosciences, Inc. | rkda-ex108_424.htm |
| EX-4.7 - EX-4.7 - Arcadia Biosciences, Inc. | rkda-ex47_403.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-229047, 333-232858, and 333-235446 on Form S-1, Registration Statements No. 333-224061 and 333-224893 on Form S-3, and Registration Statement Nos. 333-204215, 333-210023, 333-216545, 333-223805, and 333-232072 on Form S-8 of our report dated March 25, 2020, relating to the financial statements of Arcadia Biosciences, Inc., appearing in this Annual Report on Form 10-K of Arcadia Biosciences, Inc. for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
Phoenix, Arizona
March 25, 2020